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Human T-cell leukemia virus type-1 (HTLV-1) is the
causative agent of a non-Hodgkin leukemia known as
adult T cell leukemia (ATL). MicroRNAs (miRNAs) are a
class of non-coding RNAs that regulate the expression of
target genes at posttranscriptional level. Biogenesis of
miRNAs is tightly regulated and starts with the produc-
tion of pri-miRNAs by RNA polymerase II. The pri-miR-
NAs are then cleaved by Drosha in conjunction with
DGCR8 in the nucleus, generating pre-miRNAs, which
are then transferred to the cytoplasm where Dicer1
further processes the hairpin into the mature miRNAs.
With exception of few types of neoplasm, a general
downregulation of miRNAs expression has been observed
in cancers cells, mainly due to chromosomal abnormal-
ities, epigenetic changes or aberrant expression of the
miRNA biogenesis factors. Involvement of miRNAs
alteration in the HTLV-1 life cycle has recently come to
light. However, the mechanisms that regulate the expres-
sion of miRNAs biogenesis factors in ATL cells are still
largely unknown. In this study, we assessed Dicer1
expression levels in ATL patients and investigated its
transcriptional regulation in HTLV infected cell lines. We
reported a significant correlation between reduced
miRNA biogenesis and expression of HTLV-1 basic
leucine zipper factor (HBZ). We showed that Dicer1
expression was downregulated in ATL patients vs.
asymptomatic patients by qRT-PCR and western blot
analysis. We also demonstrated that Dicer1 was regulated
by AP-1 factors, through luciferase and Chip assays. Our
data suggest that Dicer1 expression may be used as a
promising prognostic marker and therapeutic target
for ATL.
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